about
Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib.A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials
P50
description
researcher
@en
name
Jeffrey A Jones
@en
type
label
Jeffrey A Jones
@en
prefLabel
Jeffrey A Jones
@en
P31
P496
0000-0001-9557-0820